A Trial of Tisotumab Vedotin in Cervical Cancer (Q63401543)
Jump to navigation
Jump to search
clinical trial
Language | Label | Description | Also known as |
---|---|---|---|
English | A Trial of Tisotumab Vedotin in Cervical Cancer |
clinical trial |
Statements
A Single Arm, Multicenter, International Trial of Tisotumab Vedotin (HuMax®-TF-ADC) in Previously Treated, Recurrent or Metastatic Cervical Cancer (English)
0 references
12 June 2018
0 references
December 2019
0 references
100
0 references
18 year
0 references